How Advances in Treatment for NSCLC and Melanoma Impact the Laboratory

During this podcast, pathology experts will discuss the impact that advances in immunotherapies for NSCLC and melanoma have in the laboratory. In addition, the podcast features an ASCP Patient Champion, who shares the patient’s perspective on the importance of a timely, accurate diagnosis. 

Faculty/Authors
Sanjay Mukhopadhyay, MD
Director, Thoracic Pathology, Department of Pathology
Pathology and Laboratory Medicine Institute, 
Cleveland Clinic, Cleveland, OH 

Lynnette Savaloja Pineault, MBA, SCT(ASCP)   
Manager, Laboratory Operations and Genetic Services
Medical Laboratory and Pathology Services
Regions Hospital, St. Paul, MN

Jim Ondick
ASCP Patient Champion

Method of Participation
To complete the activity and receive credit, the participant must complete the podcast activity. CME certificates will be provided on-line.

CME/CMLE Credit: 0.75
Estimated Completion Time: 0.75 hour
Format: Online Educational Activity

Physician Competencies: Patient Care, Medical Knowledge 

Accreditation Statement: The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).

Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this journal-based CME activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions

To claim CME/CMLE credit for the exercise, do the following:

1. Review the Technical Considerations.
2. Review the Faculty Disclosures.
3. Click Go to Course to view an overview of the modules in this course.
4. Click Access to begin the course.
5. Review the Educational Activity.
6. Submit the course Evaluation.
7. Enter the maximum number of credits offered and click Claim CME to register credit.

Faculty Disclosure

Technical Considerations

Release Date: 11/30/2023 
Review Date:
Expiration Date: 11/30/2026 

• Describe how targeted therapies and immunotherapies have improved treatment for melanoma and lung cancer

• Discuss how pathologist and laboratory professionals might improve the journey for patients with cancer

• Describe how biomarker testing benefits both early-and advanced-stage cancer patients